Titre:
  • Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study
Auteur:Yang, H.; Bouma, Berto Uva Nl B.J.; Dimopoulos, Konstantinos; Khairy, Paul; Ladouceur, Magalie; Niwa, Koichiro; Greutmann, Matthias; Schwerzmann, Markus; Egbe, Alexander Chima; Scognamiglio, Giancarlo; Budts, Werner; Veldtman, Gruschen G.R.; Opotowsky, A.R.; Broberg, Craig; Gumbiene, Lina; Meijboom, Folkert; Rutz, T.; Post, Marco M.C.; Moe, Tabitha; Lipczyńska, Magdalena; Tsai, Shane; Chakrabarti, Santabhanu; Tobler, Daniel; Davidson, William; Morissens, Lucien; Van Dijk, Arie; Buber, Jonathan; Bouchardy, Judith; Skoglund, Kristofer; Christersson, Christina; Kronvall, Thomas; Konings, Thelma T.C.; Alonso-Gonzalez, Rafael; Mizuno, Atsushi; Webb, Gary; Laukyte, Migle; Sieswerda, Gertjan Tj G.T.J.; Shafer, Keri; Aboulhosn, Jamil; Mulder, Barbara B.J.M.
Informations sur la publication:International journal of cardiology
Statut de publication:Publié, 2019
Sujet CREF:Cardiologie et circulation
Mots-clés:Adult congenital heart disease
Anticoagulation
Bleeding
NOACs
Thromboembolism
Valvular disease
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0167-5273
info:doi/10.1016/j.ijcard.2019.06.014
info:pii/S0167527318370207
info:scp/85068777903